Search Results for "Auvi-Q"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Auvi-Q. Results 1 to 3 of 3 total matches.
See also: epinephrine
In Brief: Epinephrine 1 mg Nasal Spray (neffy)
The Medical Letter on Drugs and Therapeutics • Apr 28, 2025 (Issue 1727)
generic (Mylan,3 Teva) 300.004
generic (Amneal)5 0.15 mg IM or SC 300.006
AUVI-Q (Kaléo)7 0.15 mg IM ...
The FDA has approved a 1-mg epinephrine nasal spray
(neffy - ARS Pharma) for emergency treatment of
type 1 hypersensitivity reactions including anaphylaxis
in patients ≥4 years old who weigh 15 to <30 kg. A
2-mg formulation of neffy was approved in 2024 for
use in patients who weigh ≥30 kg.
Med Lett Drugs Ther. 2025 Apr 28;67(1727):71 doi:10.58347/tml.2025.1727c | Show Introduction Hide Introduction
An Epinephrine Nasal Spray (neffy) for Anaphylaxis
The Medical Letter on Drugs and Therapeutics • Oct 14, 2024 (Issue 1713)
and functionality. AUVI-Q provides visual signals
and audio instructions, has an automatic needle
retraction ...
The FDA has approved an epinephrine nasal spray
(neffy – ARS Pharma) for emergency treatment
of type 1 hypersensitivity reactions including
anaphylaxis in patients who weigh ≥30 kg. It is
the first noninjectable epinephrine product to be
approved for this indication.
Med Lett Drugs Ther. 2024 Oct 14;66(1713):163-4 doi:10.58347/tml.2024.1713b | Show Introduction Hide Introduction
Drugs Past Their Expiration Date
The Medical Letter on Drugs and Therapeutics • Jul 27, 2020 (Issue 1603)
, EpiPen
Jr, Auvi-Q, and the generic for Adrenaclick) have
found pens up to 6 years past their expiration ...
Healthcare providers are often asked if drugs can
be used past their expiration date. Because of legal
restrictions and liability concerns, manufacturers do
not sanction such use and usually do not comment
on the safety or effectiveness of their products beyond
the date on the label. Since our last article on this
subject, more data have become available.